Part,  Chapter, Paragraph

 1   II,     5.  6.  6|      France]. Rev Rhum Ed Fr 60(6 Pt 2):63S-7S~Lin CT, Albertson
 2   II,     5.  7.  7|         Pediatrics 2003 Apr;111(4 Pt 1):e382-e387.~Atthobari
 3   II,     5.  9.  7|         Mal Respir. 2002 Oct;19(5 Pt 1):585-92~ ~Bousquet J (
 4   II,     5.  9.  7|         Rev Mal Respir.Sep; 23 (4 Pt 2):10S73-10S75~ ~Bousquet
 5   II,     7.  7    |           CZ, ES, FI, HU, LV, NL, PT, SI, SE (2004) EE, IT (2003) [
 6   II,     9.  1.  1|         Obstet Gynecol 2005;193(3 Pt 2):1076-82.~ ~Alexander
 7   II,     9.  1.  1| Obstetrics & Gynecology 1995;86(4 Pt 2):700-5.~ ~Bai J, Wong
 8   II,     9.  1.  1|         Obstet Gynecol 2005;105(5 Pt 1):983-90.~Cnattingius S (
 9   II,     9.  1.  1|         Obstet Gynecol 1993;168(1 Pt 1):16-21.~De Galan-Roosen
10   II,     9.  3.  2|         Obstet Gynecol 2005;193(3 Pt 2):1076-82.~ ~Atrash HK,
11   II,     9.  3.  2| Obstetrics & Gynecology 1995;86(4 Pt 2):700-5.~Bai J, Wong FW,
12   II,     9.  3.  2|         Obstet Gynecol 2005;105(5 Pt 1):983-90.~ ~Cnattingius
13   II,     9.  3.  2|         Obstet Gynecol 1993;168(1 Pt 1):16-21.~ ~Cnattingius
14  III,    10.  3.  2|     Persistent Organic Pollutants~Pt~Platinum~PVC~Polyvinyl chloride~
15  III,    10.  3.  2|          from car catalysts using Pt/Rh or Pd/Rh. Pd/Rh catalysts
16  III,    10.  3.  2|           more active metals than Pt/Rh catalysts (LAI 2002,
17  III,    10.  3.  2|   electronics, anti-cancer drugs (Pt), catalysts in various industrial
18  III,    10.  3.  2|         between 1 and 11 ng/l for Pt with high peaks up to 44
19  III,    10.  3.  2|          mainly attributed to the Pt and Pd compounds in their
20  III,    10.  3.  2|         settings that for soluble PT the critical levels for
21   IV,    12.  7    |           A conference during the PT Presidency on 5-6 November